Tuning In To Cough in Pulmonary Fibrosis: How Should We Address the Gap?
May 27, 2025
ATS 2025 Innovation Hub PresentationToby Maher, MD, PHD, Professor of Clinical Medicine at Keck School...
Read more »
Join Strados Labs’ Session at ATS 2025 on Cough in Pulmonary Fibrosis, led by Dr. Toby Maher
May 1, 2025
Please join Strados Labs at ATS 2025 for an engaging session on the often-overlooked symptom...
Read more »
Strados Labs to Present Developments in Cough Monitoring at ATS 2025
April 22, 2025
Strados Labs looks forward to participating in the American Thoracic Society (ATS) 2025 International Conference...
Read more »
Webinar Replay: From Symptoms to Solutions: Enhancing Interstitial Lung Disease (ILD) Trials with Next-Gen Assessments
April 8, 2025
Read more »
Strados Labs Introduces Grant Initiative to Accelerate Research into Continuous Lung Sound Monitoring
March 25, 2025
The new program provides eligible research studies with in-kind support for the use of the...
Read more »
Regulatory Pathways for Cough Monitoring in Clinical Trials: FDA Validation Requirements Explained
March 11, 2025
Cough monitoring has emerged as an increasingly common practice in research studies and drug development...
Read more »
Strados Labs Collaborates with Beth Israel Deaconess Medical Center for Innovative Study in Pulmonary Edema
February 20, 2025
The study will evaluate continuous lung sound monitoring for the early detection of pulmonary edema...
Read more »
Why the Tegaderm™ Adhesive is a Trusted, Patient-Friendly Solution for the RESP® Biosensor
January 30, 2025
In research studies and healthcare settings, minimizing patient burden is essential for reliable data collection...
Read more »
Cough as an Endpoint in IPF Trials: Why it Matters
December 4, 2024
Increased importance has been placed in recent years on the ability of idiopathic pulmonary fibrosis...
Read more »